Concepedia

Author

A. Maggio

San Raffaele University of RomeORCID

Also Known As

A Maggio, A. Angelo Maggio, A. Angelo maggio, A. Maggio, Angelo Maggio, Arianna Maggio

100

Publications

694

Citations

14

H-Index

29

Concepts

All Affiliations

San Raffaele University of RomeCandiolo Cancer InstituteIstituti di Ricovero e Cura a Carattere ScientificoFondazione IRCCS Istituto Nazionale dei TumoriOspedale Civile Di Ivrea
AM

About

A. Maggio is an author at San Raffaele University of Rome specializing in medicine, urology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

253

2

Health Sciences

3

3

69

3

Education

1

1

33

4

Engineering

1

1

17

5

Biostatistics

1

1

24

A. Maggio

×

14

Publications

559

Citations

14

H-Index

YearCitations

Pretreatment patient‐specific IMRT quality assurance: A correlation study between gamma index and patient clinical dose volume histogram

M. Stasi, S. Bresciani, A. Miranti,

Medical Physics

2012

210

Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer

V. Carillo, C. Cozzarini, T. Rancati,

Radiotherapy and Oncology

2014

48

Tomotherapy treatment plan quality assurance: The impact of applied criteria on passing rate in gamma index method

S. Bresciani, A. Di Dia, A. Maggio,

Medical Physics

2013

41

Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study

A. Maggio, Alessandro Magli, T. Rancati,

International Journal of Radiation Oncology*Biology*Physics

2014

40

Comparison of two different EPID-based solutions performing pretreatment quality assurance: 2D portal dosimetry versus 3D forward projection method

S. Bresciani, M. Poli, A. Miranti,

Physica Medica

2018

33

Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose–volume effects

C. Sini, B. Noris Chiorda, P. Gabriele,

Radiotherapy and Oncology

2017

32

Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy

F. Palorini, T. Rancati, C. Cozzarini,

Radiotherapy and Oncology

2016

24

Feasibility of safe ultra-high (EQD<sub>2</sub>&gt;100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy

A. Maggio, C. Fiorino, P. Mangili,

Acta Oncologica

2010

22

Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy

A. Maggio, Domenico Gabriele, E. Garibaldi,

Strahlentherapie und Onkologie

2017

22

Correlation between surrogates of bladder dosimetry and dose–volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy

V. Carillo, C. Cozzarini, A. Chietera,

Radiotherapy and Oncology

2012

20

Page 1